- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-hexamer
- Ligands
- 36 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 48 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.37: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain A: N.122, T.124, N.125, V.127
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain A: E.132, N.164, N.165
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain A: T.108, N.234
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain A: N.280, E.281, N.282
- Chain C: K.558
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain A: N.331, Q.580
Ligand excluded by PLIPNAG.43: 4 residues within 4Å:- Chain A: F.338, G.339, F.342, N.343
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain A: N.709, I.1130, G.1131
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.46: 5 residues within 4Å:- Chain B: N.122, A.123, T.124, N.125, V.127
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain B: E.132, N.164, N.165
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain B: T.108, N.234, T.236
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain A: K.558
- Chain B: N.280, N.282
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain B: N.331, P.579, Q.580
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain B: F.338, F.342, N.343
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain B: N.709, I.1130, G.1131
- Chain C: D.796
Ligand excluded by PLIPNAG.53: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.54: 4 residues within 4Å:- Chain C: N.122, T.124, V.127, F.157
Ligand excluded by PLIPNAG.55: 4 residues within 4Å:- Chain B: I.468
- Chain C: E.132, N.164, N.165
Ligand excluded by PLIPNAG.56: 4 residues within 4Å:- Chain B: K.462
- Chain C: T.108, N.234, T.236
Ligand excluded by PLIPNAG.57: 3 residues within 4Å:- Chain C: N.280, E.281, N.282
Ligand excluded by PLIPNAG.58: 2 residues within 4Å:- Chain C: N.331, Q.580
Ligand excluded by PLIPNAG.59: 4 residues within 4Å:- Chain C: F.338, G.339, F.342, N.343
Ligand excluded by PLIPNAG.60: 3 residues within 4Å:- Chain C: N.709, I.1130, G.1131
Ligand excluded by PLIPNAG.61: 2 residues within 4Å:- Chain D: Y.28, N.61
Ligand excluded by PLIPNAG.62: 5 residues within 4Å:- Chain D: N.122, A.123, T.124, N.125, V.127
Ligand excluded by PLIPNAG.63: 3 residues within 4Å:- Chain D: E.132, N.164, N.165
Ligand excluded by PLIPNAG.64: 3 residues within 4Å:- Chain D: T.108, N.234, T.236
Ligand excluded by PLIPNAG.65: 3 residues within 4Å:- Chain D: N.280, E.281, N.282
Ligand excluded by PLIPNAG.66: 3 residues within 4Å:- Chain D: N.331, Q.580, L.582
Ligand excluded by PLIPNAG.67: 4 residues within 4Å:- Chain D: F.338, G.339, F.342, N.343
Ligand excluded by PLIPNAG.68: 4 residues within 4Å:- Chain D: N.709, I.1130, G.1131
- Chain E: D.796
Ligand excluded by PLIPNAG.69: 2 residues within 4Å:- Chain E: Y.28, N.61
Ligand excluded by PLIPNAG.70: 5 residues within 4Å:- Chain E: N.122, T.124, N.125, V.127, F.157
Ligand excluded by PLIPNAG.71: 3 residues within 4Å:- Chain E: E.132, N.164, N.165
Ligand excluded by PLIPNAG.72: 3 residues within 4Å:- Chain E: T.108, N.234, T.236
Ligand excluded by PLIPNAG.73: 3 residues within 4Å:- Chain D: K.558
- Chain E: N.280, N.282
Ligand excluded by PLIPNAG.74: 2 residues within 4Å:- Chain E: N.331, Q.580
Ligand excluded by PLIPNAG.75: 4 residues within 4Å:- Chain E: F.338, G.339, F.342, N.343
Ligand excluded by PLIPNAG.76: 3 residues within 4Å:- Chain E: N.709, I.1130, G.1131
Ligand excluded by PLIPNAG.77: 2 residues within 4Å:- Chain F: Y.28, N.61
Ligand excluded by PLIPNAG.78: 4 residues within 4Å:- Chain F: N.122, T.124, V.127, F.157
Ligand excluded by PLIPNAG.79: 3 residues within 4Å:- Chain F: E.132, N.164, N.165
Ligand excluded by PLIPNAG.80: 3 residues within 4Å:- Chain F: T.108, N.234, T.236
Ligand excluded by PLIPNAG.81: 3 residues within 4Å:- Chain F: N.280, E.281, N.282
Ligand excluded by PLIPNAG.82: 2 residues within 4Å:- Chain F: N.331, Q.580
Ligand excluded by PLIPNAG.83: 5 residues within 4Å:- Chain F: F.338, F.342, N.343, V.367, L.368
Ligand excluded by PLIPNAG.84: 3 residues within 4Å:- Chain D: D.796
- Chain F: N.709, G.1131
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Saville, J.W. et al., Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants. Nat Commun (2022)
- Release Date
- 2022-03-30
- Peptides
- Spike glycoprotein: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-hexamer
- Ligands
- 36 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 48 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Saville, J.W. et al., Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants. Nat Commun (2022)
- Release Date
- 2022-03-30
- Peptides
- Spike glycoprotein: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F